SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021546
Filing Date
2022-11-03
Accepted
2022-11-03 07:26:14
Documents
56
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20220930.htm   iXBRL 10-Q 3170292
2 EX-10.1 dyn-ex10_1.htm EX-10.1 213640
3 EX-31.1 dyn-ex31_1.htm EX-31.1 15502
4 EX-31.2 dyn-ex31_2.htm EX-31.2 15279
5 EX-32.1 dyn-ex32_1.htm EX-32.1 7935
6 EX-32.2 dyn-ex32_2.htm EX-32.2 7825
  Complete submission text file 0000950170-22-021546.txt   8661360

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20220930_pre.xml EX-101.PRE 243043
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dyn-20220930_def.xml EX-101.DEF 109552
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20220930.xsd EX-101.SCH 35480
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20220930_lab.xml EX-101.LAB 336096
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dyn-20220930_cal.xml EX-101.CAL 35551
50 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20220930_htm.xml XML 1554320
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 221356217
SIC: 2834 Pharmaceutical Preparations